Bionano Genomics (BNGO) Share-based Compensation (2017 - 2026)

Bionano Genomics has disclosed Share-based Compensation across 10 years of filings, most recently posting $670000.0 for Q1 2026.

• Share-based Compensation for Q1 2026 came in at $670000.0, down 57.78% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.6 million (down 56.46% YoY), and the FY2025 annual result was $4.5 million, down 53.43% from the prior year.
• Share-based Compensation came in at $670000.0 for Q1 2026 at Bionano Genomics, down from $926000.0 in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $6.1 million in Q3 2022 to a low of $670000.0 in Q1 2026.
• The 5-year median for Share-based Compensation is $3.0 million (2024), against an average of $3.1 million.
• Across the five-year window, Share-based Compensation surged 1275.2% in 2022 and slumped 58.19% in 2025, its largest moves.
• Bionano Genomics' Share-based Compensation stood at $5.5 million in 2022, then plunged by 38.46% to $3.4 million in 2023, then tumbled by 42.59% to $1.9 million in 2024, then slumped by 52.17% to $926000.0 in 2025, then retreated by 27.65% to $670000.0 in 2026.
• The last three Share-based Compensation figures came in at $670000.0 (Q1 2026), $926000.0 (Q4 2025), and $941000.0 (Q3 2025), per Business Quant data.